Zachary Sticher

9PUBLICATIONS
53CO-AUTHORS
Medical infection agents (incl. prions)Pharmacology and pharmaceutical sciences not elsewhere classifiedMedical virologyMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

|Nov 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.

Stephen R Welch, Jessica R Spengler, Jonna B Westover

|Feb 08, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.

Robert M Cox, Josef D Wolf, Nicole A Lieberman

|Aug 07, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.

Robert M Cox, Carolin M Lieber, Josef D Wolf

|Jul 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model.

Carolin M Lieber, Robert M Cox, Julien Sourimant

|Dec 02, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Julien Sourimant, Carolin M Lieber, Megha Aggarwal

Pageof 2

Frequent Collaborators

8 joint publications

Richard K Plemper

5 joint publications

Jeong-Joong Yoon

5 joint publications

Meghan K Smith

5 joint publications

Josef D Wolf